Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (59)

2024

  1. Current Management of Head and Neck Paragangliomas: A Multicenter Series With Long-Term Follow-Up

    Otolaryngology - Head and Neck Surgery (United States)

  2. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

  3. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

    Pituitary

  4. Incident comorbidities in patients with chronic hypoparathyroidism after thyroidectomy: a multicenter nationwide study

    Frontiers in Endocrinology, Vol. 15

  5. Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433

  6. Long term outcomes of pituitary adenomas in Multiple Endocrine Neoplasia type 1: a nationwide study

    Frontiers in Endocrinology, Vol. 15

  7. Natural history and surgical outcomes of Rathke’s cleft cysts: a Spanish multicenter study

    Frontiers in Endocrinology, Vol. 15

  8. Prevalence of chronic postsurgical hypoparathyroidism not adequately controlled: an analysis of a nationwide cohort of 337 patients

    Frontiers in Endocrinology, Vol. 15

  9. Ultrasound Cut-Off Values for Rectus Femoris for Detecting Sarcopenia in Patients with Nutritional Risk

    Nutrients, Vol. 16, Núm. 11

2023

  1. Changing trends in transgender demographics and morbidity: baseline data from a Spanish cohort

    Sexual health, Vol. 20, Núm. 1, pp. 96-98

  2. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102

  3. Consumption of health resources in older people with differentiated thyroid carcinoma: a multicenter analysis

    Endocrine, Vol. 81, Núm. 3, pp. 521-531

  4. Pseudohypoxia in paraganglioma and pheochromocytoma is associated with an immunosuppressive phenotype

    Journal of Pathology, Vol. 259, Núm. 1, pp. 103-114

2022

  1. Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications

    Diabetes Therapy, Vol. 13, Núm. 5, pp. 873-888

  2. Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  3. Differentiated thyroid carcinoma in the elderly: influence of age on disease-free and overall survival

    Endocrine, Vol. 77, Núm. 1, pp. 121-133

  4. Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study

    Drugs in Context, Vol. 11

  5. Flash Glucose Monitoring and Diabetes Mellitus Induced by Immune Checkpoint Inhibitors: An Approach to Clinical Practice

    Journal of Diabetes Research, Vol. 2022

  6. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study

    European Thyroid Journal, Vol. 11, Núm. 5

  7. Once-Weekly Semaglutide Use in Patients with Type 2 Diabetes: Results from the SURE Spain Multicentre, Prospective, Observational Study

    Journal of Clinical Medicine, Vol. 11, Núm. 17